Suppr超能文献

饮食成分和中药对高血压的影响:肠道微生物群的潜在作用

Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota.

作者信息

Zhang Guo-Xin, Jin Ling, Jin Hua, Zheng Gui-Sen

机构信息

Basic Medical College, Gansu University of Chinese Medicine, Lanzhou 730000, China.

College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China.

出版信息

Evid Based Complement Alternat Med. 2021 Apr 20;2021:5563073. doi: 10.1155/2021/5563073. eCollection 2021.

Abstract

Hypertension (HTN) is an important worldwide public health issue affecting human health. The pathogenesis of HTN involves complex factors such as genetics, external environment, diet, and the gut microbial dysbiosis. The gut microbiota, as a medium of diet and drug metabolism, is closely correlated to host's health and disease (including HTN). Literatures were randomly collected from various databases including PubMed, ScienceDirect, Google Scholar, and China National Knowledge Infrastructure (CNKI). In this review, we elucidate the relationship between HTN and gut microbiota, as well as concerning the effects of different dietary components, diet-derived microbial metabolites, and traditional Chinese medicine (TCM) on intestinal flora. These studies have shown that diet and TCM can regulate and balance the intestinal flora, which are inclined to increasing the abundance of , , and and reducing the ratio of and . Moreover, monitoring the dynamic change of gut microflora may indicate patient prognosis and personalized response to treatment. This review aims to provide novel perspectives and potential personalized interventions for future HTN management from the perspective of gut microbiota.

摘要

高血压(HTN)是一个影响人类健康的重要全球性公共卫生问题。高血压的发病机制涉及遗传、外部环境、饮食和肠道微生物群失调等复杂因素。肠道微生物群作为饮食和药物代谢的媒介,与宿主的健康和疾病(包括高血压)密切相关。从包括PubMed、ScienceDirect、谷歌学术和中国知网(CNKI)在内的各种数据库中随机收集文献。在本综述中,我们阐明了高血压与肠道微生物群之间的关系,以及不同饮食成分、饮食衍生的微生物代谢产物和中药对肠道菌群的影响。这些研究表明,饮食和中药可以调节和平衡肠道菌群,倾向于增加 、 和 的丰度,降低 和 的比例。此外,监测肠道微生物群的动态变化可能预示患者的预后和对治疗的个性化反应。本综述旨在从肠道微生物群的角度为未来高血压管理提供新的视角和潜在的个性化干预措施。

相似文献

1
Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota.
Evid Based Complement Alternat Med. 2021 Apr 20;2021:5563073. doi: 10.1155/2021/5563073. eCollection 2021.
3
Specific Alterations of Gut Microbiota in Chinese Patients with Hypertension: A Systematic Review and Meta-Analysis.
Kidney Blood Press Res. 2022;47(7):433-447. doi: 10.1159/000524282. Epub 2022 Apr 8.
4
Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.
J Ethnopharmacol. 2021 Oct 5;278:114207. doi: 10.1016/j.jep.2021.114207. Epub 2021 May 14.
6
Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.
J Ethnopharmacol. 2023 Mar 1;303:116038. doi: 10.1016/j.jep.2022.116038. Epub 2022 Dec 15.
8
Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota.
Crit Rev Food Sci Nutr. 2019;59(6):848-863. doi: 10.1080/10408398.2018.1536646. Epub 2018 Dec 20.
9
[Interaction of effective ingredients from traditional Chinese medicines with intestinal microbiota].
Zhongguo Zhong Yao Za Zhi. 2016 May;41(10):1766-1772. doi: 10.4268/cjcmm20161002.

引用本文的文献

1
Metabolomics Insights into Gut Microbiota and Functional Constipation.
Metabolites. 2025 Apr 12;15(4):269. doi: 10.3390/metabo15040269.
2
Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of hypertension.
Front Pharmacol. 2024 Dec 9;15:1449972. doi: 10.3389/fphar.2024.1449972. eCollection 2024.
3
Application of metabolomics in quality control of traditional Chinese medicines: a review.
Front Plant Sci. 2024 Nov 15;15:1463666. doi: 10.3389/fpls.2024.1463666. eCollection 2024.
4
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.
Front Pharmacol. 2024 Oct 9;15:1442854. doi: 10.3389/fphar.2024.1442854. eCollection 2024.
5
Research Progress on the Correlation Between Hypertension and Gut Microbiota.
J Multidiscip Healthc. 2024 May 16;17:2371-2387. doi: 10.2147/JMDH.S463880. eCollection 2024.
6
The role of the gut microbiota in health and cardiovascular diseases.
Mol Biomed. 2022 Oct 11;3(1):30. doi: 10.1186/s43556-022-00091-2.
8
Altering Early Life Gut Microbiota Has Long-Term Effect on Immune System and Hypertension in Spontaneously Hypertensive Rats.
Front Physiol. 2021 Oct 29;12:752924. doi: 10.3389/fphys.2021.752924. eCollection 2021.

本文引用的文献

1
Elucidation of the Mechanisms and Molecular Targets of Decoction for Type 2 Diabetes Mellitus Based on Network Pharmacology.
Biomed Res Int. 2020 Aug 10;2020:5848497. doi: 10.1155/2020/5848497. eCollection 2020.
2
Baicalin regulates Treg/Th17 cell imbalance by inhibiting autophagy in allergic rhinitis.
Mol Immunol. 2020 Sep;125:162-171. doi: 10.1016/j.molimm.2020.07.008. Epub 2020 Jul 17.
3
The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development.
Antioxid Redox Signal. 2021 Apr 1;34(10):811-830. doi: 10.1089/ars.2020.8104. Epub 2020 May 14.
4
The global epidemiology of hypertension.
Nat Rev Nephrol. 2020 Apr;16(4):223-237. doi: 10.1038/s41581-019-0244-2. Epub 2020 Feb 5.
5
Different Effects of Premature Infant Formula and Breast Milk on Intestinal Microecological Development in Premature Infants.
Front Microbiol. 2020 Jan 17;10:3020. doi: 10.3389/fmicb.2019.03020. eCollection 2019.
6
Effects of Sanoshashinto on left ventricular hypertrophy and gut microbiota in spontaneously hypertensive rats.
J Nat Med. 2020 Mar;74(2):482-486. doi: 10.1007/s11418-020-01387-9. Epub 2020 Jan 19.
7
Antihypertensive constituents in Sanoshashinto.
J Nat Med. 2020 Mar;74(2):421-433. doi: 10.1007/s11418-019-01382-9. Epub 2020 Jan 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验